"It's no secret that the world is facing a severe water shortage; many experts, believe the next major war will be fought over water, not oil," says Marc Lichtenfeld.

The senior equity analyst for the top-notch growth stock advisory, Xcelerated Profits Report explains, "Desalination is likely the only way the world's water needs will be met. And one company that will benefit is Energy Recovery (NASDAQ: ERII).

"Just how severe is the shortage? Demand for fresh water will exceed supply by 50% in 2025, with one-third of the Earth's population living in countries with water scarcity. The bottom line is that if we plan to feed and provide water for everyone, we're going to have to find a way to use more water more efficiently.

"Carl Icahn - one of Wall Street's most renowned and successful investors - is on another mission; this pitbull is sinking his teeth into one of the companies in our portfolio - Enzon Pharmaceuticals (NASDAQ: ENZN)," notes Marc Lichtenfeld.

In Xcelerated Profits Report, the senior analyst and noted healthcare sector expert takes a look at the small cap biotechnology, which is involved in developing products for the treatment of cancer.

"With an infamous reputation for diving into stocks that he perceives as undervalued and shaking up management teams in order to boost shareholder value, Icahn us one of the best 'business partners' we could have.

"One of the big reasons why we recommended Enzon was because some major institutional investors are clamoring for change at the company. They contend that if Enzon was better at maximizing its true potential, the stock could easily vault from its current undervalued state and generate some real wealth for its shareholders.